Accretive Health Reports Inducement Grant
November 12 2014 - 5:00PM
Business Wire
Accretive Health, Inc. (OTC Pink: ACHI) today announced that, in
connection with the appointment of David Mason as the company’s
chief strategy officer, on November 11, 2014, Accretive Health
granted to Mason a nonstatutory stock option and shares of
restricted common stock (collectively the “Inducement Grants”) as
an inducement material to Mason’s acceptance of employment with the
company.
The stock option is for the purchase of 400,000 shares of the
company’s common stock, with an exercise price of $7.15, which was
the closing price of the company’s common stock reported through
the facilities of the OTC Markets Group Inc. on November 11, 2014.
The restricted stock award was a grant of 300,000 shares of
restricted common stock of the company. The Inducement Grants
generally will vest in equal annual installments over four years
following the grant date, subject to continued service with the
company. The Inducement Grants were approved by the company’s Board
of Directors and will be issued outside of the company’s 2010 Stock
Incentive Plan.
About Accretive Health
At Accretive Health, our mission is to partner with healthcare
communities to serve as a catalyst for a healthier future for all.
For more information, visit www.accretivehealth.com.
Accretive Health, Inc.Investor Relations:Atif
Rahim312-324-5476investorrelations@accretivehealth.comorMedia
Relations:Brian Pitts312.475.5921brian.pitts@hkstrategies.com
R1 RCM (NASDAQ:RCM)
Historical Stock Chart
From Aug 2024 to Sep 2024
R1 RCM (NASDAQ:RCM)
Historical Stock Chart
From Sep 2023 to Sep 2024
